{
    "clinical_study": {
        "@rank": "144580", 
        "arm_group": [
            {
                "arm_group_label": "Smartpatch Treatment Group", 
                "arm_group_type": "Experimental", 
                "description": "Subjects in the Treatment Group will have a Smartpatch Lead placed in the shoulder, will use the Smartpatch Peripheral Nerve Stimulation (PNS) System, and will receive electrical stimulation."
            }, 
            {
                "arm_group_label": "Smartpatch Control Group", 
                "arm_group_type": "Sham Comparator", 
                "description": "Subjects in the Control Group will have a Smartpatch Lead placed in the shoulder, will use the Smartpatch Peripheral Nerve Stimulation (PNS) System, but will not receive any electrical stimulation."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine if electrical stimulation (small levels of\n      electricity) reduces post-stroke shoulder pain.  This study involves a device called the\n      Smartpatch System.  The Smartpatch System delivers mild electrical stimulation to the\n      muscles in the shoulder.  The Smartpatch System includes a small wire (called a \"Lead\") that\n      is placed through the skin into the muscle of the shoulder.  It also includes a device worn\n      on the body that delivers stimulation (called the Smartpatch Stimulator)."
        }, 
        "brief_title": "Electrical Stimulation for the Treatment of Chronic Post-Stroke Shoulder Pain Using the Smartpatch System", 
        "condition": [
            "Post-stroke Shoulder Pain", 
            "Hemiplegic Shoulder Pain"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Shoulder Pain", 
                "Stroke", 
                "Cerebral Infarction"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Key Inclusion Criteria:\n\n          -  At least 21 years of age\n\n          -  Post-stroke shoulder pain\n\n          -  At least 6 months after stroke that caused shoulder pain\n\n        Key Exclusion Criteria:\n\n          -  Use of habit-forming (narcotic) medications\n\n          -  Bleeding disorder\n\n          -  History of recurrent skin infections\n\n          -  Parkinson's Disease, Spinal Cord Injury, traumatic brain injury, Multiple Sclerosis,\n             or Complex Regional Pain Syndrome\n\n          -  Heart arrhythmia or artificial heart valves\n\n          -  Uncontrolled seizures\n\n          -  Implanted Electronic Device\n\n          -  Pregnant"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "180", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01847885", 
            "org_study_id": "0131-CSP-000"
        }, 
        "intervention": {
            "arm_group_label": [
                "Smartpatch Treatment Group", 
                "Smartpatch Control Group"
            ], 
            "description": "The Smartpatch System is an Investigation Device which delivers mild electrical stimulation to the muscles in the shoulder.  The Smartpatch System includes a small wire (called a \"Lead\") that is placed through the skin into the muscle of the shoulder.  It also includes a device worn on the body that delivers stimulation (called the Smartpatch Stimulator).", 
            "intervention_name": "Smartpatch Peripheral Nerve Stimulation (PNS) System", 
            "intervention_type": "Device", 
            "other_name": "Smartpatch System, Smartpatch"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "electrical stimulation", 
            "neurostimulation", 
            "neuromodulation", 
            "post-stroke shoulder pain", 
            "hemiplegic shoulder pain"
        ], 
        "lastchanged_date": "November 21, 2013", 
        "location": [
            {
                "contact": {
                    "last_name": "Michael Schmitt", 
                    "phone": "312-238-2845"
                }, 
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60611"
                    }, 
                    "name": "Rehabilitation Institute of Chicago"
                }, 
                "investigator": {
                    "last_name": "Richard L Harvey, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Emma Kaplan", 
                    "phone": "973-243-6880"
                }, 
                "facility": {
                    "address": {
                        "city": "West Orange", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "07052"
                    }, 
                    "name": "Kessler Foundation Research Center"
                }, 
                "investigator": {
                    "last_name": "Anna M Barrett, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Carly Creelman", 
                    "phone": "212-746-1857"
                }, 
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10065"
                    }, 
                    "name": "Weill Cornell Medical Center"
                }, 
                "investigator": {
                    "last_name": "Michael W O'Dell, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Marybeth Whitney, BSN", 
                    "phone": "704-355-1409"
                }, 
                "facility": {
                    "address": {
                        "city": "Charlotte", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "28203"
                    }, 
                    "name": "Carolinas Rehabilitation/Carolinas Healthcare"
                }, 
                "investigator": {
                    "last_name": "Vu Nguyen, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Double-Blinded, Placebo-Control Multicenter Pivotal Study of the Smartpatch Peripheral Nerve Stimulation (PNS) System for the Treatment of Chronic Post-Stroke Shoulder Pain", 
        "other_outcome": [
            {
                "description": "User satisfaction survey", 
                "measure": "User Satisfaction with The Smartpatch System at End of Treatment", 
                "safety_issue": "No", 
                "time_frame": "End of Treatment (4-weeks of Treatment/Control)"
            }, 
            {
                "description": "User Satisfaction Survey", 
                "measure": "User Satisfaction with The Smartpatch System at 12-weeks beyond Treatment", 
                "safety_issue": "No", 
                "time_frame": "12-week post-treatment"
            }, 
            {
                "description": "Assessed through User Satisfaction Survey", 
                "measure": "Performance of the Smartpatch System at End of Treatment", 
                "safety_issue": "No", 
                "time_frame": "End of Treatment (4-weeks of Treatment/Control)"
            }, 
            {
                "description": "Assessed through User Satisfaction Survey", 
                "measure": "Performance of the Smartpatch System at 12-weeks beyond Treatment", 
                "safety_issue": "No", 
                "time_frame": "12-weeks post-treatment"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Change from Baseline Shoulder Pain Intensity at End of Treatment (EOT)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, End of Treatment (4-weeks of Treatment/Control)"
            }, 
            {
                "measure": "Device related adverse event rates in treatment and control groups", 
                "safety_issue": "Yes", 
                "time_frame": "1-week"
            }, 
            {
                "measure": "Device related adverse event rates in treatment and control groups", 
                "safety_issue": "Yes", 
                "time_frame": "2-weeks"
            }, 
            {
                "measure": "Device related adverse event rates in treatment and control groups", 
                "safety_issue": "Yes", 
                "time_frame": "3-weeks"
            }, 
            {
                "measure": "Device related adverse event rates in treatment and control groups", 
                "safety_issue": "Yes", 
                "time_frame": "End of Treatment (4-weeks of Treatment/Control)"
            }, 
            {
                "measure": "Device related adverse event rates in treatment and control groups", 
                "safety_issue": "Yes", 
                "time_frame": "1-week post-treatment"
            }, 
            {
                "measure": "Device related adverse event rates in treatment and control groups", 
                "safety_issue": "Yes", 
                "time_frame": "4-weeks post-treatment"
            }, 
            {
                "measure": "Device related adverse event rates in treatment and control groups", 
                "safety_issue": "Yes", 
                "time_frame": "12-weeks post-treatment"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01847885"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from Baseline Shoulder Pain Interference at End of Treatment", 
                "safety_issue": "No", 
                "time_frame": "Baseline, End of Treatment (4-weeks of Treatment/Control)"
            }, 
            {
                "measure": "Durability of change from baseline Shoulder Pain Intensity at 12-weeks beyond Treatment", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 12-wks post-treatment"
            }, 
            {
                "measure": "Change from Baseline Quality of Life at End of Treatment", 
                "safety_issue": "No", 
                "time_frame": "Baseline, End of Treatment (4-weeks of Treatment/Control)"
            }, 
            {
                "measure": "Change from Baseline Average Pain Intensity at End of Treatment", 
                "safety_issue": "No", 
                "time_frame": "Baseline, End of Treatment (4-weeks of Treatment/Control)"
            }, 
            {
                "measure": "Patient Global Impression of Change at End of Treatment", 
                "safety_issue": "No", 
                "time_frame": "End of Treatment (4-weeks of Treatment/Control)"
            }, 
            {
                "measure": "Change in Pain Medication Usage at End of Treatment", 
                "safety_issue": "No", 
                "time_frame": "End of Treatment (4-weeks of Treatment/Control)"
            }, 
            {
                "measure": "Clinical Global Impression of Improvement at End of Treatment", 
                "safety_issue": "No", 
                "time_frame": "End of Treatment (4-weeks of Treatment/Control)"
            }
        ], 
        "source": "SPR Therapeutics, LLC", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "SPR Therapeutics, LLC", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}